IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company operates through, Chemical and Pharmaceutical segments. The Chemical segment offers ethyl acetate, iso butyl benzene, acetyl chloride, mono chloro acetic acid, and acetic anhydride to food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and chemical intermediates industries. The Pharmaceutical segment provides active pharmaceutical ingredients, such as ibuprofen, metformin, fenofibrate, lamotrigine, clopidogrel bisulphate, pantoprazole sodium, ursodeoxycholic acid, losartan potassium, gabapentin, levetiracetam, and paracetamol. Its active pharmaceutical ingredients are used for the treatment of anti-inflammatory, analgesic and antipyretic, anti-diabetic, anti- platelet, anti-cholesterol, anti- convulsant, anti-epileptic, anti-hypertensive, and anti-cholelithic, as well as proton pump inhibitor. IOL Chemicals a
| Current Price | ₹131.45 |
|---|---|
| Market Cap | ₹3,858 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 28 |
| Return on Equity | 7.90% |
| 52-Week Range | ₹67.14 – ₹138.89 |
| Beta (1Y) | 0.63 |
| Dividend Yield | 0.76% |
1. Chemical-49.6% 2. Pharmaceutical-59.7% 3. Unallocated-0.9%
Iol Chemicals & Pharmaceuticals Ltd. is trading at ₹131.45, with a market capitalisation of ₹3,858 Cr.
Iol Chemicals & Pharmaceuticals Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Medicinal Chemicals and Botanical Products).
Iol Chemicals & Pharmaceuticals Ltd. has a P/E of 28 and a return on equity of 7.90%.